NDC product
TRICITRATES
NDC 0121-0677 · PAI Holdings, LLC dba PAI Pharma
Key facts
| Product NDC | 0121-0677 |
|---|---|
| Proprietary name | TRICITRATES |
| Nonproprietary name | POTASSIUM CITRATE, SODIUM CITRATE, and CITRIC ACID MONOHYDRATE |
| Substances | POTASSIUM CITRATE, SODIUM CITRATE, CITRIC ACID MONOHYDRATE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | PAI Holdings, LLC dba PAI Pharma |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| Marketing start | May 25, 2005 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: